Melatonin improves sleep in children with epilepsy: A randomized, double-blind, crossover study

Sleep Medicine

Volumn 16, Issue 5, 2015, Pages 637-644

  Jain, Sejal V ^a,b   Horn, Paul S ^a   Simakajornboon, Narong ^a,b   Beebe, Dean W ^a,b   Holland, Katherine ^a,b   Byars, Anna W ^a,b   Glauser, Tracy A ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

EEG spikes; Natural supplement; Seizure frequency; Sleep architecture; Sleep latency; WASO

Indexed keywords

CARBAMAZEPINE; ETHOSUXIMIDE; ETIRACETAM; LAMOTRIGINE; MELATONIN; OXCARBAZEPINE; PLACEBO; ZONISAMIDE; DELAYED RELEASE FORMULATION; HYPNOTIC SEDATIVE AGENT;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HUMAN; INSOMNIA; INTELLIGENCE QUOTIENT; LATENT PERIOD; MALE; MORPHOLOGY; OUTCOME ASSESSMENT; PILOT STUDY; POLYSOMNOGRAPHY; PREPUBERTY; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REACTION TIME; REM SLEEP; SALIVA LEVEL; SCHOOL CHILD; SLEEP PATTERN; SLEEP QUALITY; SLEEP TIME; SLOW WAVE SLEEP; COMPLICATION; DELAYED RELEASE FORMULATION; DRUG EFFECTS; PSYCHOMOTOR PERFORMANCE; SLEEP INITIATION AND MAINTENANCE DISORDERS;

CHILD; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MELATONIN; POLYSOMNOGRAPHY; PSYCHOMOTOR PERFORMANCE; REACTION TIME; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 84933673458     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2015.01.005     Document Type: Article

References (46)

1. Kwan P., Brodie M.J. Early identification of refractory epilepsy. N Engl J Med 2000, 342:314-319.
2. Cortesi F., Giannotti F., Ottaviano S. Sleep problems and daytime behavior in childhood idiopathic epilepsy. Epilepsia 1999, 40:1557-1565.
3. Batista B.H., Nunes M.L. Evaluation of sleep habits in children with epilepsy. Epilepsy Behav 2007, 11:60-64.
4. Vendrame M., Yang B., Jackson S., et al. Insomnia and epilepsy: a questionnaire-based study. J Clin Sleep Med 2013, 9:141-146.
5. Khatami R., Zutter D., Siegel A., et al. Sleep-wake habits and disorders in a series of 100 adult epilepsy patients - a prospective study. Seizure 2006, 15:299-306.
6. Jain S.V., Simakajornboon N., Glauser T.A. Provider practices impact adequate diagnosis of sleep disorders in children with epilepsy. J Child Neurol 2013, 28:589-595.
7. Bazil C.W., Short D., Crispin D., et al. Patients with intractable epilepsy have low melatonin, which increases following seizures. Neurology 2000, 55:1746-1748.
8. Paprocka J., Dec R., Jamroz E., et al. Melatonin and childhood refractory epilepsy - a pilot study. Med Sci Monit 2010, 16:CR389-CR396.
9. Yalyn O., Arman F., Erdogan F., et al. A comparison of the circadian rhythms and the levels of melatonin in patients with diurnal and nocturnal complex partial seizures. Epilepsy Behav 2006, 8:542-546.
10. Heussler H., Chan P., Price A.M., et al. Pharmacological and non-pharmacological management of sleep disturbance in children: an Australian Paediatric Research Network survey. Sleep Med 2013, 14:189-194.
11. Coppola G., Iervolino G., Mastrosimone M., et al. Melatonin in wake-sleep disorders in children, adolescents and young adults with mental retardation with or without epilepsy: a double-blind, cross-over, placebo-controlled trial. Brain Dev 2004, 26:373-376.
12. Goldberg-Stern H., Oren H., Peled N., et al. Effect of melatonin on seizure frequency in intractable epilepsy: a pilot study. J Child Neurol 2012, 27:1524-1528.
13. Gupta M., Aneja S., Kohli K. Add-on melatonin improves sleep behavior in children with epilepsy: randomized, double-blind, placebo-controlled trial. J Child Neurol 2005, 20:112-115.
14. Ma X., Idle J.R., Krausz K.W., et al. Metabolism of melatonin by human cytochromes. Drug Metab Dispos 2005, 33(489-494):p450.
15. Facciola G., Hidestrand M., von Bahr C., et al. Cytochrome P450 isoforms involved in melatonin metabolism in human liver microsomes. Eur J Clin Pharmacol 2001, 56:881-888.
16. Iber C. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications 2007, American Academy of Sleep Medicine, American Academy of Sleep Medicine, Westchester, IL.
17. Marzec M.L., Selwa L.M., Malow B.A. Analysis of the first night effect and sleep parameters in medically refractory epilepsy patients. Sleep Med 2005, 6:277-280.
18. Selwa L.M., Marzec M.L., Chervin R.D., et al. Sleep staging and respiratory events in refractory epilepsy patients: is there a first night effect?. Epilepsia 2008, 49:2063-2068.
19. NINDS Epilepsy Common data elements - seizure diary accessed 04.09.14. http://www.commondataelements.ninds.nih.gov/Epilepsy.aspx#tab=Data_Standards.
20. Krueger D.A., Care M.M., Holland K., et al. Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med 2010, 363:1801-1811.
21. Lim J., Dinges D.F. Sleep deprivation and vigilant attention. Ann N Y Acad Sci 2008, 1129:305-322.
22. Venker C.C., Goodwin J.L., Roe D.J., et al. Normative psychomotor vigilance task performance in children ages 6 to 11 - the Tucson Children's Assessment of Sleep Apnea (TuCASA). Sleep Breath 2007, 11:217-224.
23. Byars A.W., Byars K.C., Johnson C.S., et al. The relationship between sleep problems and neuropsychological functioning in children with first recognized seizures. Epilepsy Behav 2008, 13:607-613.
24. Sadeh A. The role and validity of actigraphy in sleep medicine: an update. Sleep Med Rev 2011, 15:259-267.
25. Shirakawa S., Tsuchiya S., Tsutsumi Y., et al. Time course of saliva and serum melatonin levels after ingestion of melatonin. Psychiatry Clin Neurosci 1998, 52:266-267.
26. Allison Bender H., Auciello D., Morrison C.E., et al. Comparing the convergent validity and clinical utility of the Behavior Assessment System for Children-Parent Rating Scales and Child Behavior Checklist in children with epilepsy. Epilepsy Behav 2008, 13:237-242.
27. Sabaz M., Lawson J.A., Cairns D.R., et al. Validation of the quality of life in childhood epilepsy questionnaire in American epilepsy patients. Epilepsy Behav 2003, 4:680-691.
28. Maganti R., Sheth R.D., Hermann B.P., et al. Sleep architecture in children with idiopathic generalized epilepsy. Epilepsia 2005, 46:104-109.
29. Erman M.K., Zammit G., Rubens R., et al. A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia. J Clin Sleep Med 2008, 4:229-234.
30. Fleiss J.L. The design and analysis of clinical experiments 1999, Wiley, New York.
31. Wasdell M.B., Jan J.E., Bomben M.M., et al. A randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities. J Pineal Res 2008, 44:57-64.
32. Braam W., Smits M.G., Didden R., et al. Exogenous melatonin for sleep problems in individuals with intellectual disability: a meta-analysis. Dev Med Child Neurol 2009, 51:340-349.
33. Guenole F., Godbout R., Nicolas A., et al. Melatonin for disordered sleep in individuals with autism spectrum disorders: systematic review and discussion. Sleep Med Rev 2011, 15:379-387.
34. Mayer G., Wang-Weigand S., Roth-Schechter B., et al. Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia. Sleep 2009, 32:351-360.
35. Roth T., Roehrs T., Vogel G. Zolpidem in the treatment of transient insomnia: a double-blind, randomized comparison with placebo. Sleep 1995, 18:246-251.
36. Zhdanova I.V., Lynch H.J., Wurtman R.J. Melatonin: a sleep-promoting hormone. Sleep 1997, 20:899-907.
37. James S.P., Sack D.A., Rosenthal N.E., et al. Melatonin administration in insomnia. Neuropsychopharmacology 1990, 3:19-23.
38. Brigo F., Del Felice A. Melatonin as add-on treatment for epilepsy. Cochrane Database Syst Rev 2012, (6). CD006967.
39. Sandyk R., Tsagas N., Anninos P.A. Melatonin as a proconvulsive hormone in humans. Int J Neurosci 1992, 63:125-135.
40. Banach M., Gurdziel E., Jedrych M., et al. Melatonin in experimental seizures and epilepsy. Pharmacol Rep 2011, 63:1-11.
41. Stewart L.S., Leung L.S. Hippocampal melatonin receptors modulate seizure threshold. Epilepsia 2005, 46:473-480.
42. Sheldon S.H. Pro-convulsant effects of oral melatonin in neurologically disabled children. Lancet 1998, 351:1254.
43. Jain S., Besag F.M. Does melatonin affect epileptic seizures?. Drug Saf 2013, 36:207-215.
44. Zhdanova I.V. Melatonin as a hypnotic: pro. Sleep Med Rev 2005, 9:51-65.
45. Sack R.L., Hughes R.J., Edgar D.M., et al. Sleep-promoting effects of melatonin: at what dose, in whom, under what conditions, and by what mechanisms?. Sleep 1997, 20:908-915.
46. Pandi-Perumal S.R., Srinivasan V., Spence D.W., et al. Role of the melatonin system in the control of sleep: therapeutic implications. CNS Drugs 2007, 21:995-1018.